MedPath

Effect of Genetic Variation in Starch-digesting Enzymes on Digestibility and Glycemic Index of Cold and Hot Rice

Not Applicable
Completed
Conditions
Carbohydrate Intolerance
Interventions
Other: Glucose
Other: Glucose plus lactulose
Other: Hot Rice
Other: Cold Rice
Registration Number
NCT03667963
Lead Sponsor
University of Toronto
Brief Summary

This study evaluates the effect of different methods of preparation (cooked and consumed hot vs cooked, cooled overnight and consumed cold) and variation in the activity of salivary amylase on the glycemic index and carbohydrate digestibility in healthy human subjects. The effect of genetic variation in small intestinal starch digesting enzymes on glycemic index and starch digestibility will also be assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Males or non-pregnant females aged 18-75 years and in good health
  • Eligible to receive income in Canada
  • Have Ontario Health Insurance Plan or equivalent medical coverage.
  • Previous donor of saliva using protocol reference number # 31093 or GIL-1670 (in which subject consents to measurement of salivary amylase activity and genetic variation in AMY1, SI and MGAM genes).
  • Salivary amylase activity in the lowest tertile (<50 U/ml) or highest tertile (>105 U/ml) of salivary amylase activity of 40 subjects previously measured.
Exclusion Criteria
  • known history of AIDS, hepatitis, diabetes or a heart condition
  • Allergy to rice, canola oil or sesame oil.
  • use of medications (including, but not limited to, insulin or other antidiabetic drugs, systemic steroids, antipsychotics, protease inhibitors, antivirals, immunosuppressive agents and drugs affecting gut motility or digestion) or with any condition which might, in the opinion of Dr. Wolever, the Medical Director or GI Labs, either: 1) make participation dangerous to the participant himself (or herself) or to others, or 2) affect the results.
  • individuals who cannot or will not comply with the experimental procedures or do not follow the instructions of GI Labs staff related to the safe performance of the experimental procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
High Salivary Amylase ActivityGlucoseGlucose Glucose plus lactulose Hot Rice Cold Rice
High Salivary Amylase ActivityGlucose plus lactuloseGlucose Glucose plus lactulose Hot Rice Cold Rice
Low Salivary Amylase ActivityGlucoseGlucose Glucose plus lactulose Hot Rice Cold Rice
Low Salivary Amylase ActivityGlucose plus lactuloseGlucose Glucose plus lactulose Hot Rice Cold Rice
Low Salivary Amylase ActivityHot RiceGlucose Glucose plus lactulose Hot Rice Cold Rice
Low Salivary Amylase ActivityCold RiceGlucose Glucose plus lactulose Hot Rice Cold Rice
High Salivary Amylase ActivityHot RiceGlucose Glucose plus lactulose Hot Rice Cold Rice
High Salivary Amylase ActivityCold RiceGlucose Glucose plus lactulose Hot Rice Cold Rice
Primary Outcome Measures
NameTimeMethod
Glycemic Index (GI)0-2 hours

For each subject, the incremental area under the glucose response curve over 2 hours (iAUC) after each rice test meal is expressed as a percentage of the mean iAUC elicited by the 2 glucose test meals.

Secondary Outcome Measures
NameTimeMethod
Breath hydrogen response0-6 hours

Sum of breath hydrogen concentrations from the lowest in the first 3 hours to 6 hours.

Carbohydrate malabsorbed0-6 hours.

For each test meal the sum of breath hydrogen concentrations from the lowest value over 0-3 hours to 6 hours (termed "H"). For each subject the amount of hydrogen per gram malabsorbed carbohydrate (H/g) is calculated as (GL-G)/10 where GL is H after the glucose plus lactose meal and G is H after the glucose meal. The amount of carbohydrate malabsorbed after the hot and cold rice meals, respectively, are HR/Hg and CR/Hg, where HR and Cr are H after the hot and cold rice meals.

Glycemic response0-2 hours

The incremental area under the blood glucose response curve

Trial Locations

Locations (1)

Glycemic Index Laboratories

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath